Seroprevalence of Helicobacter pylori in Chinese patients on continuous ambulatory peritoneal dialysis

Nephrology

Volumn 10, Issue 1, 2005, Pages 21-24

  Lui, Sing Leung ^a   Wong, Wai Man ^b   Ng, Suk Yi ^a   Chan, Tak Mao ^b   Lai, Kar Neng ^b   Lo, Wai Kei ^a  

^a TUNG WAH HOSPITAL   (Hong Kong)

^b QUEEN MARY HOSPITAL   (Hong Kong)

Author keywords

Chinese; Dyspepsia; Helicobacter pylori; Peritoneal dialysis; Serology

Indexed keywords

ALBUMIN; CREATININE; HEMOGLOBIN; HISTAMINE H2 RECEPTOR ANTAGONIST; PARATHYROID HORMONE; PROTON PUMP INHIBITOR; UREA;

ADULT; AGE DISTRIBUTION; AGED; ARTICLE; BODY MASS; BODY WEIGHT; CHINESE; CLINICAL FEATURE; CONTINUOUS AMBULATORY PERITONEAL DIALYSIS; DEMOGRAPHY; DYSPEPSIA; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HELICOBACTER INFECTION; HELICOBACTER PYLORI; HEPATITIS; HONG KONG INDEX OF DYSPEPSIA QUESTIONNAIRE; HUMAN; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; QUESTIONNAIRE; RISK FACTOR; SEROPREVALENCE;

AGED; ANTIBODIES, BACTERIAL; ASIAN CONTINENTAL ANCESTRY GROUP; DYSPEPSIA; FEMALE; HELICOBACTER INFECTIONS; HELICOBACTER PYLORI; HONG KONG; HUMANS; KIDNEY FAILURE, CHRONIC; MALE; MIDDLE AGED; PERITONEAL DIALYSIS, CONTINUOUS AMBULATORY; SEROEPIDEMIOLOGIC STUDIES;

EID: 14844310260     PISSN: 13205358     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1440-1797.2005.00367.x     Document Type: Article

References (22)

1. NIH Consensus Conference. Helicobacter pylori in peptic ulcer disease. NIH Consensus Development Panel on Helicobacter pylori in peptic ulcer diseet alase. JAMA 1994; 272: 65-9.
2. Suerbaum S, Michetti P. Helicobacter pylori infection. N. Engl. J. Med. 2002; 347: 1175-86.
3. Shousha S, Arnaout AH, Abbas SH, Parkins RA. Antral Helicobacter pylori in patients with chronic renal failure. J. Clin. Pathol. 1990; 43: 397-9.
4. Loffeld RJ, Peltenburg HG, vd Oever H, Stobberingh E. Prevalence of Helicobacter pylori antibodies in patients on chronic intermittent haemodialysis. Nephron 1991; 59: 250-3.
5. Davenport A, Shallcross TM, Crabtree JE, Davison AM, Will EJ, Heatley RV. Prevalence of Helicobacter pylori in patients with end-stage renal failure and renal transplant recipients. Nephron 1991; 59: 597-01.
6. Gladziwa U, Haase G, Handt S et al. Prevalence of Helicobacter pylori in patients with chronic renal failure. Nephrol. Dial. Transplant. 1993; 8: 301-6.
7. De Vecchi AF, Quattrini M, Boni F et al. Epidemiology of Helicobacter pylori in dialysis patients. Perit. Dial. Int. 1995; 15: 178-9.
8. Jaspersen D, Fassbinder W, Heinkele P et al. Significantly lower prevalence of Helicobacter pylori in uremic patients than in patients with normal renal function. J. Gastroenterol. 1995; 30: 585-8.
9. Luzza F, Imeneo M, Maletta M et al. Helicobacter pylori-specific IgG in chronic haemodialysis patients: Relationship of hypergastrinaemia to positive serology. Nephrol. Dial. Transplant. 1996; 11: 120-4.
10. Ozgur O, Boyacioglu S, Ozdogan M, Gur G, Telatar H, Haberal M. Helicobacter pylori infection in haemodialysis patients and renal transplant recipients. Nephrol. Dial. Transplant. 1997; 12: 289-91.
11. Munoz de Bustillo E, Sanchez Tomero JA, Sam JC et al. Eradication and follow-up of Helicobacter pylori infection in hemodialysis patients. Nephron 1998; 79: 55-60.
12. Yildiz A, Besisik F, Akkaya V et al. Helicobacter pylori antibodies in hemodialysis patients and renal transplant recipients. Clin. Transplant. 1999; 13: 13-16.
13. Tamura H, Tokushima H, Murakawa M et al. Influences of Helicobacter pylori on serum pepsinogen concentrations in dialysis patients. Nephrol. Dial. Transplant. 1999; 14: 113-17.
14. Fabrizi F, Martin P, Dixit V et al. Epidemiology of Helicobacter pylori in chronic haemodialysis patients using the new RIBA H. pylori SIA. Nephrol. Dial. Transplant. 1999; 14: 1929-33.
15. Schoonjans R, Van VB, Vandamme W et al. Dyspepsia and gastroparesis in chronic renal failure: The role of Helicobacter plyori. Clin. Nephrol. 2002; 57: 201-7.
16. Nakajima F, Sakaguchi M, Amemoto K et al. Helicobacier pylori in patients receiving long-term dialysis. Am. J. Nephrol. 2002; 22: 468-72.
17. Antoniou S, Dimitriadis A, Kliridou M, Pavlitou K, Batzili H, Malaka E. Prevalence of Helicobacter pylori antibodies in CAPD patients. Nephron 1997; 75: 358-9.
18. McColl K, Murray L, El-Omar E et al. Systematic benefit from eradicating Helicobacter pylori infection in patients with nonulcer dyspepsia. N. Engl. J. Med. 1998; 339: 1869-74.
19. Xia HH, Kalantar JS, Wyatt JM et al. High sensitivity and specificity of a laboratory-based serological test, H. pylori Dtest ELlSA, for detection of Helicobacter pylori infection. Diagn. Microbiol. Infect. Dis. 2000; 36: 69-74.
20. Xia HH, Wong BC, Wong WM et al. Optimal serological tests for the detection of Helicobacter pylori infection in the Chinese population. Aliment. Pharmacol. Ther. 2002; 16: 521-6.
21. Hu WH, Lam KF, Wong YH et al. The Hong Kong index of dyspepsia: A validated symptom severity questionnaire for patients with dyspepsia. J. Gastroenterol. Hepatol. 2002; 17: 545-51.
22. Descamps-Latscha B. The immune system in end-srage renal disease. Curr. Opin. Nephrol. Hypertens. 1993; 2: 883-91.